drugset
drugset / Trial / NCT07127458

Anxiety and Depression in Adolescent PCOS

NCT07127458 ↗

Completed 42 enrolled Ege University
NaSingle-groupOpen-labelTreatment

Summary

Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder in adolescent females, often accompanied by psychological symptoms such as anxiety and depression. These conditions are frequently underdiagnosed and untreated. This study aims to determine the prevalence of anxiety and depression in adolescents with PCOS and to assess changes following oral contraceptive use.

Timeline

Start
2025-08-17
Primary completion
2026-03-17
Completion
2026-03-17

Drugs

EvaluationDrugModalityDoseRoute
Subject drospirenone Unknown 3 mg Oral
Subject ethinyl estradiol Small molecule 30 ug Oral

Indications

polycystic ovary syndrome